Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05032820
Title MM CAR-T to Upgrade Response
Recruitment Not yet recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Marcelo Pasquini, MD
Indications

multiple myeloma

Therapies

Cyclophosphamide + Fludarabine

Idecabtagene Vicleucel + Lenalidomide

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.